4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-23-021978
Director bought 7,000 shares at $1.69 ($11,830)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jaksch Frank L Jr Director | 2023-06-12 | Purchase | +7,000 | $1.69 | $11,830 | 231,339 | D: show line 1 in the form |
| Open-market purchases · 7,000 sh · avg $1.69 · $11,830 | |||||||
Loading xslF345X04/wk-form4_1686689397.xml…